Helius Medical Technologies, Inc. is a neurotech company focused on addressing neurologic deficits with its orally applied technology platform, which enhances the brain's compensatory mechanisms. Co. develops, licenses, or acquires non-implantable technologies aimed at reducing symptoms of neurological diseases or trauma. Its key product, the Portable Neuromodulation Stimulator (PoNS), is a non-implantable device that delivers mild electrical stimulation to the tongue, aiding in the treatment of gait and chronic balance deficits. PoNS Therapy, used alongside supervised therapeutic exercises, is prescribed for patients aged 22 and over. We show 35 historical shares outstanding datapoints in our HSDT shares outstanding history coverage, used to compute HSDT market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing HSDT market cap history over the course of time is important for investors
interested in comparing HSDT's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of HSDT versus a peer is one thing; comparing
HSDT market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like HSDT can fluctuate over the course of history.
With this page we aim to empower investors researching HSDT by allowing them to research the HSDT market cap history. |
Free HSDT Email Alerts:
Video: The Importance of Market Cap
